Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

30.25
+0.83002.82%
Post-market: 30.700.4500+1.49%17:28 EDT
Volume:3.29M
Turnover:97.87M
Market Cap:2.17B
PE:-5.13
High:30.61
Open:29.09
Low:28.46
Close:29.42
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.72
T/O Rate:6.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.32
PE(LYR):-6.49

Loading ...

OverviewCompanyNewsFilings

Vera Therapeutics Grants Inducement Equity Awards to Five New Employees Under NASDAQ Rule Exemption

Reuters
·
Oct 03

Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk

Reuters
·
Oct 02

H.C. Wainwright Remains a Buy on Vera Therapeutics (VERA)

TIPRANKS
·
Oct 01

Vera Therapeutics Down over 8%, on Track for Largest Percent Decrease Since November 2025

Dow Jones
·
Sep 24

Vera Therapeutics CEO Fordyce Marshall Disposes of USD 684,500 in Common Shares

Reuters
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS) and Vera Therapeutics (VERA)

TIPRANKS
·
Sep 16

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
Sep 16

Top Midday Stories: Waystar Reportedly Mulling Potential Sale; Intel-Backed Altera Says Parent Company Files Confidentially for IPO

MT Newswires Live
·
Sep 15

Rami Katkhuda Reiterates Buy on Trutakna, Citing Strong Clinical and Early Commercial Traction; $90 Price Target Maintained

TIPRANKS
·
Sep 15

Vera Therapeutics ORIGIN 3 study results positive, says Raymond James

TIPRANKS
·
Sep 15

Vera Therapeutics Shares up 1.5% After Kidney Disease Drug Meets Goals in Confirmatory Trial

THOMSON REUTERS
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results

Dow Jones
·
Sep 15

Vera Therapeutics Reports Successful TRUTAKNA Phase 3 Results

TIPRANKS
·
Sep 15

Top Premarket Gainers

MT Newswires Live
·
Sep 15

Vera Therapeutics up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data

TIPRANKS
·
Sep 15

Vera Therapeutics Gains After Kidney Disease Drug Meets Goals in Confirmatory Trial

Reuters
·
Sep 15

Vera Therapeutics’ trutakna meets all efficacy endpoints in IgAN trial

TIPRANKS
·
Sep 15

Vera Therapeutics, - Trutakna Demonstrates Favorable Safety Profile Generally Comparable to Placebo

THOMSON REUTERS
·
Sep 15

Vera Therapeutics, - Plans to Submit Supplemental Bla to FDA for Full Approval in Q4 2026

THOMSON REUTERS
·
Sep 15
More